Merck invests to increase Brazilian production capacity
A Merck investe no aumento de capacidade de produção no Brasil
Intel ID : 227242
| Synopsis |
|
Germany-based Merck (FWB:MRK), engaged in pharmaceutical laboratory management and headquartered in Hessen, plans to invest BRL 42m to expand laboratories and factories in Brazil, specifically in Jacarepaguá, Rio de Janeiro, as reported by Valor Econômico on 16 July 2015. Merck's plan is to increase its production capacity by 30%. The factory's area would increase from 4,900 m2 to 6,500 m2.
(content in portuguese)
A companhia alemã Merck, (FWB:MRK), sediada em Hessen, prentede investir BRL 42m na ampliação dos laboratórios e fábricas que tem instaladas no Brasil, em concreto em Jacarepaguá, Rio de Janeiro, segundo publicou o Valor Econômico no dia 16 de julho de 2015. O plano da Merck é aumentar em até 30% a capacidade de produção das instalações, passando a usina a ocupar de 4.900m2 a 6.500m2. |
|
||||
| Intel ID | 227242 | |
| Value | EUR 12,27m | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Merck Group
(31 Mar 2016) |
Revenue: EUR 3.665,00m EBITDA: EUR 1.282,00m Net Debt: EUR 12.072,00m |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.